{'fraction_non_alphanumeric': 0.022878932316491896, 'fraction_numerical': 0.020495710200190656, 'mean_word_length': 5.101744186046512, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Announcement of 2014 Clinical and Experimental Neuroimmunology Best Article Award

To encourage members of The Japanese Society for Neuroimmunology, the society has been honoring the Clinical and Experimental Neuroimmunology (CENI) Best Article Award since 2013. The award nominee is selected from the original articles in regular issues or supplements of CENI, written by members of the society. Two articles are awarded every year: usually one from the clinical field, and one from the basic science field. Award winners are obliged to attend the international meeting and submit the congress report to CENI. The Editorial Committee members of CENI, comprising of four chief editors and one managing editor, evaluated the articles carefully and chose two nominees. As we already announced one of the two nominees in the previous issue, there is only one introduction in this issue. The article entitled, “Early inhibition of tumor necrosis factor-a and interleukin-6 in muscle tissue as a therapy for dystrophinopathy in mdx mice,” which appears in Clin Exp Neuroimmunol 5(3) 371– 377, 2014, was written by Dr Hajime Arahata. Dr Arahata, current Head Physician of the Department of Neurology, National Hospital Organization Omuta Hospital, Omuta, Japan, obtained his medical degree at Nagasaki University in 1997. After he joined the Department of Neurology, Graduate School of Medical Sciences, Kyushu University, in 2000, he trained as a clinical neurologist and afterwards his study focused on muscle pathology. From 2003, he continued studying muscle diseases at Omuta Hospital. He also served as a research fellow at the National Center of Neurology and Psychiatry from 2004 to 2006. This article is outstanding in the scope of treating a mouse model of dystrophinopathy, and has had a significant impact on research in muscle diseases. We would like to encourage the members of the society to submit their high-quality work to CENI. Dr Arahata attended the 21st International Annual Congress of the World Muscle Society held in Granada, Spain, and his Congress Report appears in this issue.